BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2592529)

  • 1. The WAIS-R profile: a diagnostic tool for Alzheimer's disease?
    Logsdon RG; Teri L; Williams DE; Vitiello MV; Prinz PN
    J Clin Exp Neuropsychol; 1989 Dec; 11(6):892-8. PubMed ID: 2592529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The WAIS-R profile as a cognitive marker of Alzheimer's disease: a misguided venture?
    Gfeller JD; Rankin EJ
    J Clin Exp Neuropsychol; 1991 Jul; 13(4):629-36. PubMed ID: 1918292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of age-decline resistant ("hold") WAIS subtests to Alzheimer's disease.
    Larrabee GJ; Largen JW; Levin HS
    J Clin Exp Neuropsychol; 1985 Oct; 7(5):497-504. PubMed ID: 4066906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
    Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminant analysis of WAIS results in different types of dementia and depressed patients.
    Mazzucchi A; Capitani E; Poletti A; Posteraro L; Bocelli G; Campari F; Parma M
    Funct Neurol; 1987; 2(2):155-63. PubMed ID: 3666544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interdisciplinary research strategies in geriatric psychiatry--studies and results in dementia and depressed patients].
    Wagner O; Oesterreich K; Hoyer S
    Z Gerontol; 1987; 20(4):195-203. PubMed ID: 3660917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic utility of savings scores: differentiating Alzheimer's and Huntington's diseases with the logical memory and visual reproduction tests.
    Tröster AI; Butters N; Salmon DP; Cullum CM; Jacobs D; Brandt J; White RF
    J Clin Exp Neuropsychol; 1993 Sep; 15(5):773-88. PubMed ID: 8276935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some aspects of memory disorders clearly distinguish dementia of the Alzheimer's type from depressive pseudo-dementia.
    Gainotti G; Marra C
    J Clin Exp Neuropsychol; 1994 Feb; 16(1):65-78. PubMed ID: 8150890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A WAIS-R marker for accelerated aging and dementia, Alzheimer's type? Base rates of the Fuld formula in the WAIS-R standardization sample.
    Satz P; Hynd GW; D'Elia L; Daniel MH; Van Gorp W; Connor R
    J Clin Exp Neuropsychol; 1990 Oct; 12(5):759-65. PubMed ID: 2258435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WAIS-R marker for dementia of the Alzheimer type? An empirical and statistical induction test.
    Satz P; Van Gorp WG; Soper HV; Mitrushina M
    J Clin Exp Neuropsychol; 1987 Dec; 9(6):767-74. PubMed ID: 3693533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the diagnostic utility of the Fuld cholinergic deficit profile on the Japanese WAIS-R.
    Yamashita H; Hirono N; Ikeda M; Ikejiri Y; Imamura T; Shimomura T; Mori E
    J Clin Exp Neuropsychol; 1997 Apr; 19(2):300-4. PubMed ID: 9240488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wechsler Intelligence Scale profiles, the cholinergic system, and Alzheimer's disease.
    Filley CM; Kobayashi J; Heaton RK
    J Clin Exp Neuropsychol; 1987 Apr; 9(2):180-6. PubMed ID: 3558750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fuld's formula and WAIS subtests in differential diagnosis of dementia.
    Caffarra P; Scaglioni A; Malvezzi L; Girotti F; Soliveri P; Musicco M; Previdi P
    Funct Neurol; 1991; 6(1):23-7. PubMed ID: 2055547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WAIS-R subtest profile and cortical perfusion in Alzheimer's disease.
    Alexander GE; Prohovnik I; Stern Y; Mayeux R
    Brain Cogn; 1994 Jan; 24(1):24-43. PubMed ID: 8123262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
    Matsuda A; Kazui H; Hirono N; Mori E
    No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivational symptoms of depression mask preclinical Alzheimer's disease in elderly subjects.
    Bartolini M; Coccia M; Luzzi S; Provinciali L; Ceravolo MG
    Dement Geriatr Cogn Disord; 2005; 19(1):31-6. PubMed ID: 15383743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analytic study on EEG features of aging with/without psychiatric disorders: focussing at the alterations in the EEGs of the healthy, depressive and demented elderlies].
    Saito N
    Seishin Shinkeigaku Zasshi; 1995; 97(10):801-24. PubMed ID: 8552725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WAIS-R performance in dementia with and without depression.
    Gfeller JD; Margolis RB
    Psychol Rep; 1990 Dec; 67(3 Pt 2):1389-90. PubMed ID: 2084767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The profile of memory disturbance in early Lewy body dementia differs from that in Alzheimer's disease].
    Mormont E; Laurier-Grymonprez L; Baisset-Mouly C; Pasquier F
    Rev Neurol (Paris); 2003 Sep; 159(8-9):762-6. PubMed ID: 13679718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.